Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc (APUS) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
apus · market cap & enterprise value · FMP · as of Jun 9, 2026
Core market cap & key metrics
As of Jun 9, 2026, Apimeds Pharmaceuticals US, Inc (APUS) has a market cap — also referred to as its net worth or valuation — of $1,396,060, making it one of the top most valuable companies globally. Market Cap = $1.11 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Apimeds Pharmaceuticals US, Inc (APUS) has a market cap — also referred to as its net worth or valuation — of $1,396,060 as of Jun 9, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Apimeds Pharmaceuticals US, Inc reached its all-time high market cap of $63,273,883.636 on Nov 17, 2025. Comparing the Apimeds Pharmaceuticals US, Inc market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Apimeds Pharmaceuticals US, Inc net worth vs peers and ask how Apimeds Pharmaceuticals US, Inc valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
APUS market cap · 6 questionsApimeds Pharmaceuticals US, Inc's net worth — measured as market capitalization — is $1,396,060 as of Jun 9, 2026. It ranks #0 globally. Market Cap = $$1.11 (price) × shares outstanding.